XML 72 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Expense, Net
 9 Months Ended
Sep. 27, 2014
Other Nonoperating Income (Expense) [Abstract]  
Other Expense, Net
OTHER EXPENSE, NET
The Company’s other expense, net consisted of the following (in millions):
 
Three Months Ended
 
Nine Months Ended
 
September 27, 2014
 
September 28, 2013
 
September 27, 2014
 
September 28, 2013
Interest income
$
(1
)
 
$
(1
)
 
$
(3
)
 
$
(4
)
Interest expense
21

 
21

 
63

 
60

Other
—

 
(3
)
 
1

 
192

Other expense, net
$
20

 
$
17

 
$
61

 
$
248


During the first nine months of 2013, the Company fully redeemed its $700 million principal amount of 5-year, 3.75% unsecured senior notes originally due in 2014 and its $500 million principal amount of 10-year, 4.875% unsecured senior notes originally due in 2019. In connection with the redemption of these notes, prior to their scheduled maturities, the Company recognized a $161 million debt retirement charge to other expense primarily associated with make-whole redemption payments and the write-off of unamortized debt issuance costs. The Company also recognized a $29 million charge to other expense to adjust the carrying value of the pre-existing CardioMEMS equity investment and fixed price purchase option to fair value during the first nine months of 2013.
The Company classifies realized gains or losses from the sale of investments as other income or expense. During the third quarter of 2014, the Company recognized a $3 million realized gain in other income from the sale of an available-for-sale security. During the third quarter and first nine months of 2013, the Company recognized $4 million and $9 million of realized gains associated with the sale of available-for-sale securities.